Dry socket paste is a compounded medicated dressing placed into an extraction socket after irrigation and gentle debridement. The classic formulas combine an obtundent such as eugenol with a topical anesthetic such as benzocaine in a carrier that holds the mixture against exposed bone. The dressing is palliative rather than curative: alveolar osteitis is a self-limiting complication and the socket epithelializes on its own, so the purpose of a dressing is to cover denuded bone and blunt pain while that happens.
This page is written for dentists and oral surgeons. It covers presentation and timing, the risk factors reported in the observational literature, what the classic dressing components are, what the evidence does and does not support, and how an order reaches the pharmacy. Dose, formula and appropriateness for a given patient are the treating clinician's decisions, and further practice-facing detail is on our information for prescribers page.
What is alveolar osteitis, and when does it present?
Alveolar osteitis, commonly called dry socket, is a postoperative complication of dental extraction in which the blood clot in the socket is lost or breaks down before the socket has healed, leaving alveolar bone exposed to the oral environment. It is not primarily an infective process, although a secondary infection can complicate it.
The characteristic history is pain that begins or sharply worsens two to four days after the extraction, after an initial period of improvement. The pain is typically severe, poorly localized and radiates to the ear, temple or angle of the mandible on the affected side. Patients frequently report halitosis and a foul taste.
On examination the socket looks empty or contains grey, disintegrating material rather than an organized clot, and bone is visible or can be probed. Incidence is reported to be considerably higher after removal of mandibular third molars than after routine extractions, and surgical extractions carry more risk than simple ones.
Reported incidence figures vary widely between studies because case definitions and follow-up intervals differ, so a single number is not worth quoting. The consistent finding across those studies is the difference by site: mandibular third molar sockets account for a disproportionate share of cases, and the mandible generally is affected more often than the maxilla.
Which patients are at higher risk?
The risk factors below come from observational studies and reviews rather than from randomized work, and the strength of each association varies between reports. They are useful for identifying patients worth counselling in advance, not for predicting an individual outcome.
- Smoking, and tobacco use in the days around the extraction.
- Oral contraceptive use, and the estrogen phase of the cycle in some reports.
- Traumatic or difficult extraction, including prolonged surgical extraction.
- Mandibular sites, particularly third molars.
- A prior episode of alveolar osteitis.
- Poor oral hygiene and pre-existing pericoronitis or periodontal disease.
- Vigorous rinsing, spitting or negative pressure from a straw in the early postoperative days.
How is alveolar osteitis distinguished from a socket infection?
The distinction matters because the two are managed differently, and because antibiotics have no role in uncomplicated alveolar osteitis. The features below are the ones that usually separate them at the chair.
| Feature | Alveolar osteitis | Socket infection |
|---|---|---|
| Onset | Days 2 to 4 | Variable |
| Pain | Severe, radiating, poorly localized | Localized, throbbing |
| Socket contents | Empty, bone visible | Purulence, granulation tissue |
| Swelling | Minimal | Often present |
| Systemic signs | Absent | Fever, lymphadenopathy possible |
Presentations overlap, and a socket can be both denuded and secondarily infected. Where systemic signs are present, or where a patient is immunocompromised, the decision about antibiotics is a clinical one and sits outside anything a dressing addresses.
What is done before a dressing is placed?
Irrigation is the first step. Most protocols call for copious irrigation of the socket with warm sterile saline or a chlorhexidine solution to remove food debris and disintegrated clot, followed by gentle debridement of loose material. Aggressive curettage of the socket walls is generally avoided, since the intention is to leave the bony surfaces undisturbed rather than to provoke fresh bleeding.
Analgesia is managed alongside this. Most patients are handled with oral analgesics, and the dressing is an adjunct rather than a substitute for them. Practices that want to reduce reliance on oral opioids for postoperative dental pain may find our post on compounded alternatives to opioids a useful summary of what is compounded in that space.
A dressing is then placed at the clinician's discretion, usually as a small amount of medicated paste on a carrier strip or gauze, or as a gel expressed directly into the socket. Patients are normally reviewed in a few days, and the socket is reassessed at each visit.
What goes into a compounded dry socket dressing?
There is no single standard formula. The combination that appears most often in the older dental literature and in commercial dressings is eugenol, benzocaine and balsam of Peru, and compounded versions are built around the same components with variations the prescriber specifies. Aspirin, chlorobutanol, guaiacol, lidocaine and a corticosteroid such as prednisolone all appear in individual practice formulas.
| Component | Usual role | Status | Evidence |
|---|---|---|---|
| Eugenol | Obtundent, from clove oil | Compounded, not FDA-approved | Older, limited |
| Benzocaine | Topical anesthetic | Compounded, not FDA-approved | Older, limited |
| Balsam of Peru | Vehicle, mild antiseptic | Compounded, not FDA-approved | No trials |
| Chlorobutanol | Antiseptic, weak anesthetic | Compounded, not FDA-approved | No trials |
| Lidocaine | Topical anesthetic | Compounded, off-label | Limited |
Every one of these preparations is compounded and is therefore not FDA-approved and not reviewed by the FDA for safety or effectiveness. Applying a topical anesthetic into an open extraction socket is an off-label route for the drugs involved. The dressing is dispensed against a prescription written for a named patient, and the formula is whatever the prescriber writes.
What does the evidence for medicated dressings actually show?
It is thin, and it is worth saying so plainly. The published work on medicated socket dressings is largely older, consists of small studies with varied designs and endpoints, and does not amount to a modern evidence base. Reviews of alveolar osteitis management have repeatedly noted the poor quality and heterogeneity of the available trials.
What that means in practice is that a dressing should be understood as symptomatic management. Alveolar osteitis resolves as the socket granulates and epithelializes, typically over one to two weeks, whether or not a dressing is used. No dressing has been shown to shorten that process, and none of the components listed above should be described to a patient as curing the condition.
Prevention has a somewhat better literature than treatment. Chlorhexidine used around the time of extraction, and smoking cessation in the perioperative period, are the interventions most often cited, and both sit with the practice rather than with the pharmacy.
The gap between the weak evidence and the routine use of these dressings is not unusual in dentistry, and it is not by itself an argument against placing one. It does mean the claim being made should stay modest. A dressing is a way of covering exposed bone and reducing what the patient feels between visits, and describing it in stronger terms than that is not supported by what has been published.
What are the drawbacks of eugenol-containing dressings?
Eugenol is cytotoxic to fibroblasts and other cells in laboratory studies, and the effect is concentration dependent. The concern raised in the literature is that a eugenol-rich dressing left in a socket may irritate soft tissue and delay the granulation it is meant to protect, which is one reason many clinicians limit both the amount placed and the number of placements.
Most of these dressings are also non-resorbable, so they need to be removed. A dressing left in place indefinitely can act as a foreign body and provoke a local reaction, and retrieval at a follow-up visit is part of the plan rather than an optional extra. Patients should be told the dressing is coming out.
Component-specific cautions apply as well. Benzocaine applied to mucosa carries a recognized risk of methemoglobinemia, and the FDA has issued safety communications about benzocaine products used in the mouth. Balsam of Peru is a well-documented contact allergen and appears on standard patch test series. Neither is a reason not to prescribe, but both belong in the conversation.
What should patients be told after a dressing is placed?
The counselling that goes with a socket dressing is short but it changes how the following days go. Patients need to know that the dressing is temporary, that it will be taken out, and that they should return if pain escalates again rather than assuming the dressing has failed.
Three points are worth stating explicitly at the chair. The dressing is for symptoms and does not shorten healing. The socket will close over one to two weeks regardless. And the same behaviours that raise the risk of losing a clot in the first place, smoking above all, apply just as much once a dressing is in place.
Patients also ask what the dressing tastes like. Eugenol-containing pastes have a strong clove flavour that most people notice immediately, and warning them in advance avoids a phone call. Anyone with a known balsam of Peru or fragrance allergy should be identified before a dressing containing it is placed.
What else is compounded for post-extraction and oral mucosal problems?
Socket dressings are one part of what dental practices order from a compounding pharmacy. Several other preparations come up regularly in oral surgery and general dentistry, and each of them is prepared to a prescriber's own specification.
Post-extraction bleeding in anticoagulated patients is the usual reason for an antifibrinolytic mouth rinse, and tranexamic acid is compounded as an oral rinse as well as in capsule, topical and intranasal forms. Its use as a rinse after dental extraction in patients on oral anticoagulants is reported in the dental and hematology literature.
Painful mucosal lesions, mucositis and denture-related ulceration are the usual reasons a prescriber writes for magic mouthwash, which is mixed to the prescriber's own combination rather than to a standard recipe.
For localized inflammatory lesions of the oral mucosa, compounded triamcinolone is prepared as a mucosal paste or as a rinse in strengths that are not commercially manufactured.
Where a topical anesthetic is wanted outside the socket itself, compounded lidocaine cream and ointment can be prepared at a strength the prescriber specifies rather than at the concentrations stocked commercially.
Temporomandibular pain frequently sits alongside dental complaints, and a topical pain cream combining agents chosen by the prescriber is a common request from that side of a practice.
The routes, bases and combinations used for jaw and facial pain are covered in more depth in our post on compounded medications for temporomandibular joint disorders.
What does Bayview compound for dental practices?
Bayview prepares socket pastes and gels to a practice's own formula, using components including eugenol, benzocaine, balsam of Peru, chlorobutanol, lidocaine and, where specified, a corticosteroid, in a carrier suitable for placement in a socket. We also prepare oral rinses, mucosal pastes and topical creams for dental and oral surgery use. Non-sterile preparations of this kind are made under USP 795 non-sterile compounding standards.
What we prepare for dental and oral surgery practices is summarized on our dental compounding services page.
Preparations for pain of dental and facial origin sit in the pain and palliative care section of the catalog, which is where most of the rinses, gels and creams a dental practice orders are grouped.
Everything we hold formulas for, across dentistry and every other therapy area, is listed in the searchable catalog of compounded medications.
There is one structural point worth stating clearly. Bayview is a 503A pharmacy, so every preparation is made against a prescription written for a named patient rather than produced as office stock for a practice to draw from. The difference between that model and both retail dispensing and outsourcing facility production is set out in our post on compounding and retail pharmacies.
How to order
Send the prescription electronically or by fax with the patient's name, the components and concentrations you want, the base or carrier, the quantity and your directions for placement and removal. If you prescribe a socket dressing regularly, our pharmacists can keep your formula on file so subsequent prescriptions reference it directly.
Our pharmacists are available to talk through components, concentrations and carriers before you write, including questions about compatibility and about which strengths are practical to prepare. A prescription is required in every case, and the formula on the prescription is the formula we prepare.
Compounded preparations are not billed through insurance, because a patient-specific preparation has no national drug code for a plan to adjudicate against, so payment is made directly to the pharmacy. Questions about cost, about how prescriptions reach us and about the states where Bayview is licensed are answered on our frequently asked questions page.
Frequently asked questions
Why would a provider prescribe compounded medication?
Compounding allows customization of strength, dosage form, ingredients, and combinations not available commercially.
In practice that looks like a custom oral suspension for a patient who cannot swallow a tablet, fortified eye drops at a concentration no commercial drop is made in, or a topical pain cream that puts several actives in one base. Compounded preparations are not FDA-approved and require a valid prescription.
How do providers send a prescription to Bayview?
Providers can submit a prescription three ways:
- E-prescribe: Search Bayview Pharmacy, Warwick, RI (NCPDP 4106882) in your EHR. For compounds, use the compound, custom, or free-text option and include the full formulation, strength, quantity, refills, and directions.
- Fax: Send a signed order to 401-284-4506 (alt. 401-210-2757) with patient and prescriber details, medication, quantity, refills, directions, signature, and date.
- Phone: Call 401-284-4505 to submit, clarify, or coordinate refills.
A valid prescription is required, and compounded medications are not FDA-approved.
How do I e-prescribe to Bayview?
Search your e-prescribing system for Bayview Pharmacy, 3844 Post Road, Warwick, RI 02886 — NCPDP 4106882.
Use your system’s compound, custom, or free-text option rather than forcing the order into a commercial NDC. An NDC-based entry describes a manufactured product, not the preparation you want, and it usually means we have to call you back.
Include the complete formulation: every active ingredient with its strength or concentration, the base or vehicle, the dosage form, the total quantity, full directions, and the number of refills. The more complete the order, the less likely we are to interrupt you for a clarification.
Controlled substances must come through EPCS. Non-controlled prescriptions can also be faxed to 401-284-4506 (alternate 401-210-2757) or called in to 401-284-4505.
If you would like help wording a formulation before you send it, call us and one of our pharmacists will work through it with you.
Can Bayview supply medication for office use?
No. Bayview is a 503A compounding pharmacy, which means every preparation we make is compounded pursuant to a valid prescription for an identified individual patient.
We do not supply office-use stock, clinic or agency stock, or pre-filled kits held for whichever patient needs them next. Non-patient-specific stock is the role of a 503B outsourcing facility, and Bayview is not one.
What we can do is turn patient-specific orders around quickly. Standard compounding is 24 to 48 business hours once we have a valid prescription and any clarifications, and expedited handling is available when a case genuinely cannot wait. For practices that order the same preparations regularly, our pharmacists are glad to work through the timing so your patients are not left waiting.
Call us at 401-284-4505 to talk through how this would work for your practice.
Can prescribers consult with your pharmacists?
Yes. Our pharmacists are available to discuss formulation options, dosing, and alternatives.
Do you help providers choose formulations?
Yes. We routinely assist providers in selecting appropriate compounded formulations.
Can patients contact you before their provider sends a prescription?
Yes. Patients may contact us to discuss options and pricing in advance.
What states do you ship to?
Bayview fills and ships prescriptions for patients in Rhode Island, Massachusetts, Connecticut, New Jersey, New Hampshire, Florida, New York, and Maine.
One exception applies in New York: we do not ship controlled substances to New York addresses at this time. Non-controlled medications, including most of our compounded preparations, ship normally, and we are working to expand what we can offer patients in New York.
If you are not sure whether your prescription is affected, call us at (401) 284-4505 and we will check before anything is prepared.
How much do compounded medications cost?
Pricing varies depending on ingredients and formulation complexity.
Do you accept insurance?
Most compounded medications are not covered by insurance. We can always try and run your insurance prior to compounding your prescription if you wish.
What is in magic mouthwash?
The version most people mean combines three ingredients in equal parts (1:1:1): diphenhydramine, an antacid such as aluminum and magnesium hydroxide, and viscous lidocaine.
But magic mouthwash is a nickname, not a defined medicine. There is no standard recipe and no FDA-approved product, and formulas vary between hospitals, clinics, and individual prescribers. Some add a steroid, an antifungal, or an antibiotic. What is in your bottle is whatever your prescriber ordered, so read your label.
What is it used for?
It is used to ease the pain of mouth sores and oral mucositis, the raw, inflamed lining of the mouth and throat that often follows chemotherapy or radiation. It is also widely used in hospice and palliative care, where keeping the mouth comfortable enough to talk, eat, and drink matters a great deal. It eases symptoms; it does not treat what caused them.
How is the oral rinse different from the paste?
The 0.1% dental paste is pressed onto one sore and forms a film that holds the steroid there. The compounded rinse, 0.1%, 0.2%, or 0.4%, is swished around the whole mouth for the time on your label and spat out, so it reaches sores on the gums, palate, and back of the mouth that a paste cannot cover. Neither is swallowed, and you should not eat or drink for 30 minutes afterward. The paste is FDA-approved for temporary relief of sore, inflamed spots from trauma; the rinse is a compounded preparation and is not FDA-approved. Your prescriber chooses between them.
What is it prescribed for?
Prescribers use topical lidocaine for nerve pain in a limited area, such as the pain that can linger after shingles, to numb intact skin before injections and minor procedures, and for localized itch or irritation. Higher strengths are usually applied in the office. Your prescriber decides whether it is appropriate for you and at what strength.
What Bayview compounds for this
Important: Compounded medications are prepared to a prescriber's order for an individual patient. They are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. This article is educational and is not a substitute for advice from your prescriber or pharmacist.
This preparation contains a controlled substance. Controlled-substance prescriptions carry refill limits, must be e-prescribed, and can only be shipped to states where Bayview holds the required licensure.
Uses discussed here may be off-label, meaning they are not part of any FDA-approved labeling. Off-label use is a decision for you and your prescriber, based on the available evidence.
Veterinary preparations are compounded to a veterinarian's order for a specific animal and are not FDA-approved animal drugs. Never give a compounded human medication to an animal without veterinary direction.
Compounded prescriptions are paid for directly rather than billed through insurance. Most are HSA/FSA-eligible, and many patients submit the receipt to their plan for possible reimbursement. Pricing depends on the strength, dose form and quantity your prescriber orders. Read more about cost and insurance.
Bayview Pharmacy is an NABP-accredited compounding pharmacy in Warwick, Rhode Island, licensed to fill and ship compounded prescriptions for patients in Rhode Island, Massachusetts, Connecticut, New Jersey, New Hampshire, Florida, New York and Maine. Controlled substances are not shipped to New York addresses. See where we ship and how to get started.
Related reading
